Small-Cap
Ideal Power Advances Commercialization of B-TRAN® Technology with New EV Industry Order
Tier 1 Automotive Supplier to Evaluate B-TRAN® for Next-Generation Solid-State EV Contactor Applications Ideal Power (IPWR), a leading developer of...
MIRA Pharmaceuticals Secures Key Publication for Ketamir-2, a Next-Gen Ketamine Analog
Peer-reviewed journal spotlights differentiated pharmacology and therapeutic promise for neuropathic pain MIRA Pharmaceuticals (MIRA), a clinical-stage biotech firm focused on...
Ideal Power Signs Strategic Distribution Deal With Kaimei Electronic Corp
Partnership with Kaimei Electronic to Promote B-TRAN Technology Across Key Power Electronics Sectors Ideal Power (IPWR), a leading innovator in...
Telomir Pharmaceuticals Reports Breakthrough Anti-Aging Results in Preclinical Werner Syndrome Model
Lead candidate Telomir-1 reverses aging markers, restores muscle mass, and boosts survival in genetic progeria model Telomir Pharmaceuticals (TELO), a...
Telomir Pharmaceuticals Reports Breakthrough in Oral Therapy for Vision Loss
Telomir-1 reverses retinal degeneration and restores vision in advanced AMD zebrafish model Telomir Pharmaceuticals (TELO) announced a major preclinical breakthrough...
Telomir Pharmaceuticals Secures $3M Premium Equity Investment to Advance Rare Disease Program
Insider-Led Funding with No Warrants Strengthens Balance Sheet Ahead of IND Submission for Telomir-1 Telomir Pharmaceuticals (TELO), a biotech innovator...
Institutional Interest In Telomir Pharmaceuticals
Telomir Pharmaceuticals (TELO) has caught the attention of institutional investors, with JPMorgan Chase & Co. (JPM) significantly increasing its position...
KindlyMD and Nakamoto Merge to Launch Largest Bitcoin Treasury Initiative in Public Markets
$710 Million Raised as David Bailey Leads Ambitious Plan to Transform Bitcoin Adoption Through Public Equity In a landmark move...
Mira Pharmaceuticals Approves Acquisition of SKNY, Creating $60M+ Biotech Platform
Board approves merger following independent valuation; SKNY to contribute $5M in cash or assets at closing Mira Pharmaceuticals (MIRA), a...
WeTouch Secures $100M Deal, Signaling Major Expansion in Touchscreen Market
Landmark agreement with multinational electronics giant paves way for global growth and innovation WeTouch Technology (WETH), a global provider of...
